James Mulé
Directeur/Membre du Conseil chez CG ONCOLOGY, INC.
Fortune : - $ au 31/05/2024
Profil
James J.
Mulé currently works at CG Oncology, Inc., as Independent Director from 2018, Moffitt Technologies Corp., as Director from 2009, Translational Research In Oncology, as Executive Vice President, and ORI Capital Investment Advisory Hong Kong Ltd., as Advisors.
Dr. Mulé also formerly worked at Empower AI, Inc., as Director, the University of Michigan, as Director-Tumor Immunology & Immunotherapy, National Cancer Institute, as Director, H.
Lee Moffitt Cancer Center & Research Institute, Inc., as EVP & Associate Center Director, Fulgent Genetics, Inc., as Independent Director from 2016 to 2020, Stanford University, as Adjunct Faculty, and Select BioVentures LLC, as Advisor.
Dr. Mulé received his undergraduate degree in 1974 from New Jersey City University, graduate degree in 1977 from UW Medicine, and doctorate degree from UW Graduate School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CG ONCOLOGY, INC.
-.--% | 25/03/2024 | 0 ( -.--% ) | - $ | 31/05/2024 |
Postes actifs de James Mulé
| Sociétés | Poste | Début |
|---|---|---|
| CG ONCOLOGY, INC. | Directeur/Membre du Conseil | 22/10/2018 |
| Moffitt Technologies Corp. | Directeur/Membre du Conseil | 01/01/2009 |
| Translational Research In Oncology | Corporate Officer/Principal | - |
ORI Capital Investment Advisory Hong Kong Ltd.
 ORI Capital Investment Advisory Hong Kong Ltd. Investment ManagersFinance ORI Capital Investment Advisory Hong Kong Ltd (ORI Capital) is a venture capital firm in Hong Kong. The firm was founded by Simone Song in 2015. The firm is headquartered in Hong Kong. | Consultant / Advisor | - |
Anciens postes connus de James Mulé
| Sociétés | Poste | Fin |
|---|---|---|
| FULGENT GENETICS, INC. | Directeur/Membre du Conseil | 27/05/2020 |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Directeur/Membre du Conseil | - |
| NCI INC | Corporate Officer/Principal | - |
Select BioVentures LLC
 Select BioVentures LLC Investment ManagersFinance Founded in 2012, Select BioVentures LLC is a venture capital firm located in Palm Beach, Florida. | Consultant / Advisor | - |
| University of Michigan | Corporate Officer/Principal | - |
Formation de James Mulé
| New Jersey City University | Undergraduate Degree |
| UW Graduate School | Doctorate Degree |
| UW Medicine | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| FULGENT GENETICS, INC. | Health Services |
| CG ONCOLOGY, INC. | Health Technology |
| Entreprise privées | 7 |
|---|---|
H. Lee Moffitt Cancer Center & Research Institute, Inc.
 H. Lee Moffitt Cancer Center & Research Institute, Inc. Miscellaneous Commercial ServicesCommercial Services H. Lee Moffitt Cancer Center & Research Institute, Inc. provides research & contributions to clinical trials, prevention and cancer control. The firm operates as National Cancer Institute (NCI) Comprehensive Cancer Center. The company was founded by Lee H. Moffitt in 1981 and is headquartered in Tampa, FL. | Commercial Services |
Select BioVentures LLC
Select BioVentures LLC Investment ManagersFinance Founded in 2012, Select BioVentures LLC is a venture capital firm located in Palm Beach, Florida. | Finance |
Empower AI, Inc.
 Empower AI, Inc. Information Technology ServicesTechnology Services Empower AI, Inc. engages in the provision of commercial artificial intelligence (AI) technology solutions defense, intelligence, health, and civilian government agencies. It offers advanced analytics and data science, engineering and logistics, information technology (IT) sustainment and modernization, IT service management, and AI solutions. The company was founded in 1989 and is headquartered in Reston, VA. | Technology Services |
| Moffitt Technologies Corp. | |
| Translational Research In Oncology | |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Miscellaneous |
ORI Capital Investment Advisory Hong Kong Ltd.
ORI Capital Investment Advisory Hong Kong Ltd. Investment ManagersFinance ORI Capital Investment Advisory Hong Kong Ltd (ORI Capital) is a venture capital firm in Hong Kong. The firm was founded by Simone Song in 2015. The firm is headquartered in Hong Kong. | Finance |
